HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FTIR spectroscopy study of PTHrP(1-34) involved in humoral hypercalcaemia of malignancy.

Abstract
The components of secondary structure of the biologically-active N-terminal domain of human parathyroid-hormone-related protein (residues 1-34) and several truncated species were examined using Fourier transform infrared (FTIR) spectroscopy. The major structural features include a segment of alpha-helix within the N-terminal segment probably extending from Glu-4 to Lys-11 with three beta-turns localized to the segments Gly-12 to Ile-15, Gln-16 to Arg-20 and His-25 to Ala-29. Some beta-sheet was detected in the full-length peptide, but not in any of the C-terminal truncated samples. These structural features were studied in the smaller peptides for the purpose of localization of the various components and with a view to describing the region likely to form the bulk of the receptor binding site.
AuthorsD R McFarlane, E F McFarlane, J A Barden, B E Kemp
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1162 Issue 1-2 Pg. 187-94 (Mar 05 1993) ISSN: 0006-3002 [Print] Netherlands
PMID8448183 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amides
  • Neoplasm Proteins
  • Parathyroid Hormone
  • Parathyroid Hormone-Related Protein
  • Peptide Fragments
  • Proteins
  • Teriparatide
  • parathyroid hormone-related protein (1-34)
Topics
  • Amides (chemistry)
  • Amino Acid Sequence
  • Humans
  • Hypercalcemia (blood, etiology)
  • Molecular Sequence Data
  • Neoplasm Proteins (chemical synthesis, chemistry)
  • Parathyroid Hormone (chemical synthesis, chemistry)
  • Parathyroid Hormone-Related Protein
  • Peptide Fragments (chemical synthesis, chemistry)
  • Protein Structure, Secondary
  • Proteins
  • Spectrophotometry, Ultraviolet (methods)
  • Teriparatide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: